INUSpheresis®
INUSpheresis® is a special form of high-tech blood plasma purification.
In this biophysical elimination procedure, the patient's entire blood plasma is passed through a special filter and thereby freed from various harmful substances.
INUSpheresis® thus helps the body to rid itself of harmful metabolic products:
- various environmental toxins
- Heavy metals that have accumulated in the body
- Complex infectious toxins
- Microplastics
- pathogenic antibodies
- Inflammatory substances (interleukins, TNF alpha)
- Lipids such as cholesterol, etc.
- pathogenic proteins (paraproteins, tumour-associated proteins, circulating immune complexes, pathoproteins, haptens)
In the 48 hours after the first INUSpheresis® , the entire body tissue releases harmful substances into the blood plasma again due to the "deep mobilisation" (osmotic gradient/ negative pressure) created by the first INUSpheresis®. Therefore, it is recommended to have a second INUSpheresis® performed after 48 hours in order to benefit maximally from the treatment.
INUSpheresis® is a gentle, very well-tolerated procedure that relieves the organism and carries hardly any risks if it is carried out with the necessary care. Each patient receives a completely new filter and tubes for the treatment, which are disposed of afterwards, so there is no risk of infection from previously treated patients.
Patients report improvements in the following areas of life and improvements in diseases:
- Improvements in microcirculation (no more cold hands and feet)
- Reductions in autoimmune diseases
- Improvement in dementia (Alzheimer's and other forms)
- Improvement of various autoimmune diseases (incl. rheumatism)
After the treatment, many patients also report better memory and concentration, more energy and subjectively feel "younger" and "healthier" again.
- Chronic inflammatory demyelinating polyneuropathy (CIDP)
- Diabetic foot syndrome
- Dilated cardiomyopathy
- Dementia (various forms, incl. Alzheimer's disease)
- Eaton-Lambert syndrome
- Multiple sclerosis
- Familial hypercholesterolaemia
- Glomerulonephritis (inflammatory kidney disease)
- Guillain-Barré syndrome
- Haemophilia (bleeding disorder)
- Inhibitor haemophilia (bleeding tendency)
- HLA sensitisation in kidney transplantation
- IgM-associated polyneuropathy (tumour-associated nerve disease)
- Autoimmune vasculitis
- Dermatosis
- Lupus erythematosus
- Behçet's disease
- Macular degeneration - dry courseRaynaud's disease
- Refsum disease (memory disease)
- Nephrotic syndrome (kidney disease)
- Side effects of chemotherapy
- Peripheral arterial occlusive disease
- Retinopathy pigmentosa
- Rheumatoid arthritis
- Scleroderma
- Stiff Man Syndrome
- Thrombangiitis obliterans
- Graft vasculopathy after heart transplantation
- Ulcerative colitis
- Xanthogranulomatosis
Appointments for INUSpheresis® treatments
If you have any questions or would like to make an appointment, please write to us:
General information on INUSpheresis®
Example of the eluate of an INUSpheresis®
All these substances in the indicated amounts were removed from the patient's blood in the course of an INU.
Dates possible from February 2023.